Receives Zero 483 observations
Strides Shasun announced that its API manufacturing site at Cuddalore was recently inspected by US FDA. The Company has successfully completed this inspection with Zero 483 observations.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)